Why a $700 million move into Qantas shares is turning heads today

Man sitting in a plane seat works on his laptop.

Qantas Airways Ltd (ASX: QAN) shares are drifting lower on Friday, giving back ground despite a steady recovery earlier this month.

At the time of writing, the Qantas share price is down 0.60% to $9.105. That leaves the stock sitting roughly 12% lower for 2026, even after bouncing from recent lows.

The move comes as fresh filings and external reporting highlight activity happening behind the scenes.

Here’s what investors are looking at.

A large institutional buyer steps in

According to The Australian, AustralianSuper has been building a position in Qantas as the share price weakened through March.

Regulatory filings show the super fund has now emerged as a substantial holder, with a stake of about 5.3%. That equates to roughly $723 million at current market prices.

The buying appears to have been spread across several weeks. The largest single-day purchase was around $100 million worth of shares on 20 March.

Accumulation has continued into April, including further buying around the time Qantas flagged a material increase in fuel costs.

The purchases were made during a period of share price weakness and rising fuel cost concerns.

Buying through weakness raises interest

Qantas has been dealing with a mix of falling share prices and elevated cost pressures.

Management recently indicated that higher fuel prices could add between $500 million and $800 million to its fuel bill. The airline has also flagged capacity adjustments and pricing responses.

These factors have weighed on the share price across recent months.

Despite that, AustralianSuper has continued to build its position, pointing to a longer-term view on earnings instead of focusing on near-term cost pressure.

The fund already has exposure to airport infrastructure through IFM Investors, including stakes in Melbourne and Sydney airports.

Share price still reflects a reset year

Even with recent buying support, the share price still shows the impact of changing expectations in 2026.

After a strong run in prior periods, the stock has spent much of this year adjusting to a different operating backdrop.

Fuel costs, capacity settings, and pricing power have all come back into focus. This has changed how the market is valuing near-term earnings.

The recent lift shows buying at lower levels, though the stock is still below earlier highs.

Foolish Takeaway

I see Qantas as one of those stocks many investors end up owning over time. It is Australia’s national carrier, with a position that is hard to replicate and tied closely to domestic travel demand.

People still need to fly, whether for work, family, or holidays, which underpins demand across the cycle. Earnings can move with fuel costs and economic conditions, but the core business remains well supported.

For me, it sits more as a long-term hold than a short-term trade.

The post Why a $700 million move into Qantas shares is turning heads today appeared first on The Motley Fool Australia.

Should you invest $1,000 in Qantas Airways Limited right now?

Before you buy Qantas Airways Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Qantas Airways Limited wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.